BECN1 and prostate carcinoma: In addition, reduced BECN1/Vps15/Vps34 complex activity mediated by the interaction of BECN1 with androgen receptor can inhibit ERK-mediated growth factor signaling and suppress the growth of castration-resistant prostate cancer [58].